about
A computational pipeline for quantification of pulmonary infections in small animal models using serial PET-CT imagingAdvancing Biological Understanding and Therapeutics Discovery with Small-Molecule ProbesLack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret modelHost gene expression signatures discriminate between ferrets infected with genetically similar H1N1 strainsA global perspective on hantavirus ecology, epidemiology, and diseaseDiscovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2Meeting report: Tenth International Conference on Hantaviruses.Early host responses of seasonal and pandemic influenza A viruses in primary well-differentiated human lung epithelial cellsCharacterization of (18)F-dipicolylamine (DPA) derivatives in cells infected with influenza virus.Lower Respiratory Tract Infection of the Ferret by 2009 H1N1 Pandemic Influenza A Virus Triggers Biphasic, Systemic, and Local Recruitment of Neutrophils.Molecular imaging reveals a progressive pulmonary inflammation in lower airways in ferrets infected with 2009 H1N1 pandemic influenza virus.Phenotypic differences in virulence and immune response in closely related clinical isolates of influenza A 2009 H1N1 pandemic viruses in mice.Evidence of Hantavirus Infection Among Bats in Brazil.A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals.Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteinsDevelopment and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound library.High-throughput screening of a 100,000-compound library for inhibitors of influenza A virus (H3N2).HTS-driven discovery of new chemotypes with West Nile Virus inhibitory activity.Transcriptome sequencing and development of an expression microarray platform for the domestic ferretEssential amino acids of the hantaan virus N protein in its interaction with RNA.De-novo transcriptome sequencing of a normalized cDNA pool from influenza infected ferrets.Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virusA cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virusNovel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanismsTreatment of hantavirus pulmonary syndromeOptimization of potent and selective quinazolinediones: inhibitors of respiratory syncytial virus that block RNA-dependent RNA-polymerase complex activity.Computer-aided pulmonary image analysis in small animal models.Accurate and efficient separation of left and right lungs from 3D CT scans: A generic hysteresis approach.Efficient ribcage segmentation from CT scans using shape features.Mathematical Modeling of Viral Zoonoses in WildlifePotential importance of error catastrophe to the development of antiviral strategies for hantaviruses.(S)-N-(2,5-Dimethylphenyl)-1-(quinoline-8-ylsulfonyl)pyrrolidine-2-carboxamide as a small molecule inhibitor probe for the study of respiratory syncytial virus infection.S. macrurus myogenic regulatory factors (MRFs) induce mammalian skeletal muscle differentiation; evidence for functional conservation of MRFs.A habitat-based model for the spread of hantavirus between reservoir and spillover species.Ribavirin protects Syrian hamsters against lethal hantavirus pulmonary syndrome--after intranasal exposure to Andes virusThe SARS-CoV ferret model in an infection-challenge study.Hantavirus infection in people inhabiting a highly endemic region of the Gran Chaco territory, Paraguay: association with Trypanosoma cruzi infection, epidemiological features and haematological characteristics.Ribavirin causes error catastrophe during Hantaan virus replication.Synthesis and anti-Hantaan virus activity of N(1)-3-fluorophenyl-inosine.Rate of hepatitis C viral clearance by human livers in human patients: Liver transplantation modeling primary infection and implications for studying entry inhibition.
P50
Q22001019-EDC4F7DE-81E9-4C65-8929-DF22ECF306AFQ26829985-B1A35C04-B84E-4107-8F8F-B30A83A63AF9Q27317179-3BE67A0F-D66C-44CD-AC72-763EF8E6DE16Q27334151-E400EAE6-D97E-49E5-9514-84B482BF8EBDQ28279096-85CD8D5A-C7A7-4194-8B7D-F63A6A4F471FQ28540101-DBE12946-CCF5-4C6A-9E0F-6F308EDFD418Q30248373-07B01623-6BA7-40F3-B738-3A35205FE39BQ30355703-76CE5716-8546-4980-AA95-C950753B86BEQ30370099-0A95ABC4-98E7-4DB8-BF65-4F63D63C2CFAQ30375527-2A3DCDFF-2516-4E68-951B-41CF4C7F9A53Q30420539-F1B1350D-808E-49BA-9B68-7AE11BE20A84Q30427596-E8E3729A-5046-4A77-8504-EE546AA646FFQ30972664-1AF2C058-CD69-43EA-B40A-94C9DD057350Q33253709-2153692A-9AB2-4EE8-9336-E4E09521A2CAQ33257614-8863F9F9-4E0A-4F88-9C95-8EFBCB96E250Q33268016-A22D5455-86ED-461A-AC24-8FD38D7F4297Q33371468-7983E698-69E2-40B1-829A-DDDDF0D22B75Q33545613-75EF5295-74EA-4DA4-A4EC-C5DB7FAE1543Q33559135-DFA8FA61-17F4-4C3E-8053-21E562BCAD1BQ33908831-A4843DF3-DCC3-4082-AE2C-3B3DC96ADE39Q34273872-E2E63F4E-35CD-4918-978C-2FE2B27CAA62Q34394138-FCA83E05-4B94-4094-81D5-AC15D3F46205Q34542805-CA9200C6-4F73-4C64-9526-4ECFA1C9A475Q34725136-F4F15B77-CD45-4309-920C-362E292F7506Q34727873-7FCFCA2B-C493-4990-9A07-725D3B869BDAQ34796481-7049273C-8B18-4F6C-B7CA-D7D618D7C0B1Q35726204-756D2802-86EC-4914-99E3-522FC1D87F4BQ35800306-B73F604A-27A3-47CB-982A-D09F1C0FD342Q35800333-80024875-6C03-4EA8-B90C-3459629F01A9Q35982583-4F5F2A9D-E409-4FEE-8C85-727D7C230964Q36008895-754595D5-CDB5-4610-91B7-4DFDB63858F6Q36422466-F9ECA82D-E67A-41F7-A915-983F54438D33Q37263839-8F161926-8834-47DD-85BD-E0F90BD287F4Q37353426-4979DFD2-CA71-4DAE-AA9B-DEAAA1438457Q37376384-319E3DB6-F7FB-435E-A125-5404D2239FAAQ39370292-59B0982C-608C-4DB0-B941-9E06D48FCCA3Q39652136-04D94943-E649-47A2-955A-5C7851199E6CQ39698441-499BC923-32E5-4C53-A52F-F2ACF5C2298BQ39842025-20D44E5A-85A8-4A18-92EE-836BA625DBB2Q40113286-28B9AD33-5625-4250-882B-2918F186B22C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Colleen B Jonsson
@nl
Colleen B Jonsson
@sl
Colleen B. Jonsson
@en
Colleen B. Jonsson
@es
type
label
Colleen B Jonsson
@nl
Colleen B Jonsson
@sl
Colleen B. Jonsson
@en
Colleen B. Jonsson
@es
prefLabel
Colleen B Jonsson
@nl
Colleen B Jonsson
@sl
Colleen B. Jonsson
@en
Colleen B. Jonsson
@es
P106
P1153
7102791844
P2798
P31
P3835
colleen-jonsson2
P496
0000-0002-2640-7672